With immediate effect, Carolin Schambach is assuming management of the Healthcare unit at Edelman and therefore the number one among healthcare communications consultants. As Executive Director, she will follow in the footsteps of Martin Flörkemeier who is moving to the US pharmaceutical and biotechnology company Gilead Sciences. She is therefore responsible for the entire multinational healthcare team based in Frankfurt.
Carolin Schambach has more than 15 years of marketing and communications experience in the healthcare sector. She has developed strategic communications and marketing concepts for numerous national and international companies. After working at Ketchum Pleon and MW Office, she was responsible for the strategic development of key clients, including AbbVie, Biogen and Novo Nordisk, in her role as Business Director for the Medical Consulting Group. This qualified nutrition scientist avails of extensive healthcare expertise in the areas of RX/OTX/OTC pharmaceuticals, medical products and health food. She is moving from the marketing agency Territory to Edelman.
“With Carolin Schambach, we have gained a top-class specialist and perfect successor for Martin Flörkemeier who succeeded in recent years in developing the Healthcare Unit at Edelman to the best PR team in Germany in the healthcare sector”, claims CEO Ernst Primosch. “I am very much looking forward to continuing our success story with Carolin.”
Edelman tops this year’s Pfeffer PR ranking in the Healthcare sector with a fee turnover of almost 10 million euros.